《Advances In Therapy》是一本以English為主的未開放獲取國際優(yōu)秀期刊,中文名稱治療進(jìn)展,本刊主要出版、報(bào)道醫(yī)學(xué)-MEDICINE, RESEARCH & EXPERIMENTAL領(lǐng)域的研究動態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果,介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展,探討行業(yè)發(fā)展的思路和方法,以促進(jìn)學(xué)術(shù)信息交流,提高行業(yè)發(fā)展。該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄,為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動作用,也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為3.4,最新CiteScore 指數(shù)為7.2。
本刊近期中國學(xué)者發(fā)表的論文主要有:
The Importance of Integrated Regulation Mechanism of Coronary Microvascular Function for Maintaining the Stability of Coronary Microcirculation: An Easily Overlooked Perspective
Peripheral T-reg Levels and Transforming Growth Factor-beta (TGF beta) in Patients with Psoriatic Arthritis: A Systematic Review Meta-Analysis
Author: Su, Qin-Yi; Zhang, Sheng-Xiao; Yang, Liu; Luo, Jing; Li, Xiao-Feng; Zhang, Jia-Qi; Zhang, Yan; Liu, Jun-Qi; Shi, Lei
Identification and Validation of a Novel Glycolysis-Related Gene Signature for Predicting the Prognosis and Therapeutic Response in Triple-Negative Breast Cancer
Advances in Therapy is an international, peer reviewed, rapid-publication (peer review in 2 weeks, published 3–4 weeks from acceptance) journal dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of therapeutics and interventions (including devices) across all therapeutic areas. Studies relating to diagnostics and diagnosis, pharmacoeconomics, public health, epidemiology, quality of life, and patient care, management, and education are also encouraged.
The journal is of interest to a broad audience of healthcare professionals and publishes original research, reviews, communications and letters. The journal is read by a global audience and receives submissions from all over the world. Advances in Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of all scientifically and ethically sound research.
中科院SCI分區(qū)
Advances In Therapy雜志中科院分區(qū)信息
2023年12月升級版
綜述:否
TOP期刊:否
大類:醫(yī)學(xué) 3區(qū)
小類:
MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué):研究與實(shí)驗(yàn) 3區(qū)
PHARMACOLOGY & PHARMACY 藥學(xué) 3區(qū)
2022年12月升級版
綜述:否
TOP期刊:否
大類:醫(yī)學(xué) 3區(qū)
小類:
MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué):研究與實(shí)驗(yàn) 3區(qū)
PHARMACOLOGY & PHARMACY 藥學(xué) 3區(qū)
2021年12月舊的升級版
綜述:否
TOP期刊:否
大類:醫(yī)學(xué) 3區(qū)
小類:
PHARMACOLOGY & PHARMACY 藥學(xué) 3區(qū)
MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué):研究與實(shí)驗(yàn) 4區(qū)
2021年12月基礎(chǔ)版
綜述:否
TOP期刊:否
大類:醫(yī)學(xué) 3區(qū)
小類:
MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué):研究與實(shí)驗(yàn) 3區(qū)
PHARMACOLOGY & PHARMACY 藥學(xué) 3區(qū)
2021年12月升級版
綜述:否
TOP期刊:否
大類:醫(yī)學(xué) 3區(qū)
小類:
PHARMACOLOGY & PHARMACY 藥學(xué) 3區(qū)
MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué):研究與實(shí)驗(yàn) 4區(qū)
2020年12月舊的升級版
綜述:否
TOP期刊:否
大類:醫(yī)學(xué) 3區(qū)
小類:
MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué):研究與實(shí)驗(yàn) 3區(qū)